| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 03/05/2003 | EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 03/05/2003 | EP1288199A1 Mmp-12 inhibitors |
| 03/05/2003 | EP1287006A1 Antitumoral compounds |
| 03/05/2003 | EP1286997A1 6-phenylpyrrolopyrimidinedione derivatives |
| 03/05/2003 | EP1286961A1 Sulfonated perfluorovinyl functional monomers |
| 03/05/2003 | EP1019368B1 Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same |
| 03/05/2003 | EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS |
| 03/05/2003 | EP0833626B1 Mono- and disulfo-substituted anthraquinones and their use for the treatment of bone matrix disorders |
| 03/05/2003 | CN1400969A Fused imidazolium derivatives |
| 03/05/2003 | CN1400207A Sulfonamide phenylalkylamine compound, its preparation method and application |
| 03/04/2003 | US6528532 Benzenesulfonamide group |
| 03/04/2003 | US6528528 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
| 02/27/2003 | WO2003016300A1 Ortho-substituted aryl amides for controlling invertebrate pests |
| 02/27/2003 | WO2003016285A1 Method of preparing 4-(imidazole-1-il)benzenesulphonamide derivatives |
| 02/27/2003 | WO2003016270A2 Selective estrogen receptor modulators |
| 02/27/2003 | WO2003016269A1 5-amidino-n-(2-aminophenethyl)-n-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor |
| 02/27/2003 | WO2003016254A1 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient |
| 02/27/2003 | WO2003016246A1 Fluorous nucleophilic substitution of alcohols and reagents for use therein |
| 02/27/2003 | WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof |
| 02/27/2003 | WO2002089740A3 Sulfonamides |
| 02/27/2003 | WO2002072542A3 Ph-dependent nmda receptor antagonists |
| 02/27/2003 | US20030040626 Method for the production of N-(5-amino-2-cyano-4-fluoro-phenyl)-sulphonamides and new intermediate products |
| 02/27/2003 | US20030040483 Compounds with growth hormone releasing properties |
| 02/27/2003 | US20030040434 Color developers; recording images |
| 02/27/2003 | CA2457482A1 5-amidino-n-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, and intermediate therefor |
| 02/27/2003 | CA2457468A1 Carboxylic acid derivatives and pharmaceutical agent comprising the same as active ingredient |
| 02/26/2003 | EP1285911A2 Arylsulfonanilide ureas |
| 02/26/2003 | EP1285902A1 Method for labeling with tritium |
| 02/26/2003 | EP1284961A1 Glycinamides |
| 02/26/2003 | EP1284959A1 Compounds for modulating the rage receptor |
| 02/26/2003 | CN1102142C Novel N-acyl sulphonamides, novel mixtures of herbicides and antidotes and their use |
| 02/25/2003 | US6525211 Herbicidal sulphonylamino(thio)carbonyl compounds |
| 02/25/2003 | US6525127 Alkylated fluorochemical oligomers and use thereof in the treatment of fibrous substrates |
| 02/25/2003 | US6525099 N-substituted sulfonamide derivatives |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/25/2003 | US6525024 Sulfonimide (substituted) acyl dipeptidyl compounds |
| 02/25/2003 | CA2039401C Preparation of optically active norbornyl amine derivatives |
| 02/21/2003 | WO2002020462A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/21/2003 | CA2419722A1 Benzoic acid derivatives and drugs containing the same as the active ingredient |
| 02/20/2003 | WO2003014296A2 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2002060874A8 Potassium channel inhibitors |
| 02/20/2003 | WO2002048097B1 Compounds, compositions and methods for treatment of parasitic infections |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | US20030036569 Do not readily protonate (even in aqueous solutions of low pH), commonly encountered in many extreme applications due to the very low basicity of the perfluorinated anion. |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/20/2003 | CA2455754A1 Amine derivatives |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1398249A Perfluoroisopropylbenzene derivatives |
| 02/19/2003 | CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 02/18/2003 | US6521667 Calcilytic compounds |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521663 Aminoguanidinyl- and Alkoxyguanidinyl-substituted phenyl acetamides as protease inhibitors |
| 02/18/2003 | US6521658 Cell proliferation inhibitors |
| 02/18/2003 | US6521650 Amines as pharmaceutical agents |
| 02/18/2003 | US6521432 Methods for enhancing the rate of modification of metastable bonds |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/14/2003 | WO2002018326A1 Novel propenohydroxamic acid derivatives |
| 02/14/2003 | CA2423733A1 Novel propenohydroxamic acid derivatives |
| 02/13/2003 | WO2003012900A1 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
| 02/13/2003 | US20030032814 Process for preparing optically active amino acid derivatives |
| 02/13/2003 | US20030032665 Method of inhibiting matrix metalloproteinases |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/12/2003 | EP1283521A2 Optical information recording medium and novel immonium compound |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518303 Selectively inhibit COX-2 in preference to COX-1 and are useful in the treatment of COX-2 mediated diseases, such as inflammation, pain, fever and asthma with fewer side effects |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/06/2003 | WO2003010136A1 Organometallic complexes, catalysts containing the same, and process for preparation of carboxylic esters |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 02/06/2003 | US20030027859 3-aryl-2-hydroxypropionic acid derivative I |
| 02/06/2003 | US20030027849 2,2-difluoro-3-acylaminopropionic acid derivatives for treatment of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism and obesity. |
| 02/06/2003 | US20030027847 Carboxyformylacetamide derivatives for treatment of AIDS or ARC |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | EP1281391A1 Organic insoluble UV filters of the aryl vinylene ketone type and their use in cosmetics |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1086078B1 Neuropeptide y5 receptor antagonists |
| 02/05/2003 | EP1027329B1 Dofetilide polymorphs |
| 02/05/2003 | EP0841913B1 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
| 02/05/2003 | CN1395560A Glyburide composition |
| 02/05/2003 | CN1100755C Aminophenyl ketone derivative and preparation method thereof |
| 02/05/2003 | CN1100754C Method for producing trifluoroacetoacetic acid anilides |
| 02/04/2003 | US6515173 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/04/2003 | US6515156 Stereoselective, efficient catalyst for synthesis of enantiomerically pure compounds; comprising compex of transition metal and aminophosphine ligand |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515028 Glucamine compounds for treating hepatitis virus infections |
| 02/04/2003 | US6515026 Potentiators of glutamate receptor function |
| 02/04/2003 | US6515025 Use of ethynyl alanine amino diol compounds to inhibit enzymatic conversion of angiotensinogen to angiotensin I |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 01/30/2003 | WO2003008374A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | WO2003007931A1 Sulfonamide derivatives |